Luen Thai Holdings Ltd
HKEX:311
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Luen Thai Holdings Ltd
HKEX:311
|
HK |
|
Immunovia AB (publ)
STO:IMMNOV
|
SE |
Balance Sheet
Balance Sheet Decomposition
Luen Thai Holdings Ltd
Luen Thai Holdings Ltd
Balance Sheet
Luen Thai Holdings Ltd
| Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
25
|
31
|
59
|
148
|
107
|
97
|
76
|
68
|
60
|
79
|
106
|
128
|
141
|
153
|
101
|
75
|
73
|
69
|
57
|
89
|
94
|
76
|
55
|
55
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
76
|
68
|
60
|
79
|
106
|
128
|
141
|
153
|
101
|
75
|
73
|
69
|
57
|
89
|
94
|
76
|
55
|
55
|
|
| Cash Equivalents |
25
|
31
|
59
|
148
|
107
|
97
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
42
|
40
|
22
|
60
|
60
|
101
|
77
|
25
|
190
|
3
|
8
|
14
|
9
|
10
|
34
|
29
|
1
|
0
|
|
| Total Receivables |
85
|
64
|
82
|
77
|
103
|
108
|
114
|
118
|
123
|
130
|
168
|
206
|
209
|
194
|
138
|
130
|
132
|
134
|
128
|
114
|
82
|
100
|
123
|
163
|
|
| Accounts Receivables |
79
|
59
|
75
|
71
|
94
|
100
|
108
|
110
|
115
|
124
|
160
|
172
|
179
|
162
|
125
|
125
|
127
|
129
|
103
|
90
|
65
|
79
|
104
|
163
|
|
| Other Receivables |
6
|
6
|
7
|
5
|
9
|
8
|
6
|
8
|
8
|
6
|
8
|
34
|
30
|
32
|
14
|
5
|
5
|
5
|
25
|
24
|
17
|
21
|
19
|
0
|
|
| Inventory |
81
|
68
|
63
|
65
|
65
|
65
|
76
|
62
|
79
|
80
|
96
|
113
|
110
|
93
|
65
|
65
|
88
|
100
|
71
|
73
|
83
|
65
|
56
|
56
|
|
| Other Current Assets |
12
|
11
|
9
|
7
|
16
|
13
|
21
|
41
|
27
|
22
|
22
|
22
|
26
|
19
|
28
|
30
|
41
|
29
|
49
|
62
|
53
|
46
|
46
|
1
|
|
| Total Current Assets |
204
|
174
|
213
|
296
|
292
|
283
|
330
|
329
|
311
|
370
|
451
|
571
|
563
|
485
|
523
|
303
|
342
|
346
|
315
|
348
|
312
|
287
|
280
|
274
|
|
| PP&E Net |
62
|
59
|
72
|
84
|
91
|
93
|
118
|
105
|
106
|
98
|
113
|
128
|
111
|
104
|
60
|
86
|
109
|
157
|
167
|
160
|
148
|
130
|
111
|
103
|
|
| PP&E Gross |
62
|
59
|
72
|
84
|
91
|
93
|
118
|
105
|
106
|
98
|
113
|
128
|
111
|
104
|
60
|
86
|
109
|
157
|
167
|
160
|
148
|
130
|
111
|
0
|
|
| Accumulated Depreciation |
47
|
50
|
55
|
64
|
78
|
78
|
106
|
117
|
136
|
149
|
165
|
197
|
203
|
208
|
153
|
159
|
157
|
160
|
186
|
181
|
179
|
188
|
189
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
10
|
28
|
26
|
24
|
22
|
20
|
18
|
20
|
29
|
14
|
12
|
1
|
0
|
5
|
4
|
4
|
3
|
3
|
2
|
1
|
43
|
|
| Goodwill |
3
|
3
|
4
|
12
|
25
|
39
|
45
|
45
|
45
|
45
|
42
|
46
|
36
|
36
|
34
|
34
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
0
|
8
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
5
|
5
|
57
|
3
|
2
|
7
|
10
|
10
|
11
|
17
|
45
|
7
|
20
|
22
|
14
|
9
|
11
|
4
|
4
|
2
|
6
|
6
|
5
|
5
|
|
| Other Long-Term Assets |
6
|
4
|
8
|
10
|
8
|
10
|
16
|
14
|
36
|
45
|
17
|
20
|
19
|
18
|
11
|
12
|
11
|
10
|
6
|
6
|
7
|
8
|
7
|
7
|
|
| Other Assets |
3
|
3
|
4
|
12
|
25
|
39
|
45
|
45
|
45
|
45
|
42
|
46
|
36
|
36
|
34
|
34
|
42
|
42
|
42
|
42
|
42
|
42
|
42
|
0
|
|
| Total Assets |
279
N/A
|
245
-12%
|
354
+45%
|
415
+17%
|
446
+7%
|
457
+3%
|
542
+19%
|
525
-3%
|
528
+1%
|
593
+12%
|
687
+16%
|
814
+18%
|
771
-5%
|
684
-11%
|
642
-6%
|
444
-31%
|
520
+17%
|
563
+8%
|
539
-4%
|
562
+4%
|
519
-8%
|
475
-8%
|
446
-6%
|
431
-3%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
87
|
75
|
74
|
90
|
120
|
125
|
147
|
138
|
143
|
152
|
198
|
226
|
114
|
202
|
162
|
130
|
142
|
121
|
72
|
81
|
173
|
144
|
127
|
97
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
24
|
26
|
16
|
23
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
26
|
14
|
36
|
28
|
26
|
31
|
40
|
42
|
41
|
28
|
34
|
32
|
49
|
64
|
29
|
24
|
34
|
31
|
21
|
0
|
|
| Current Portion of Long-Term Debt |
42
|
30
|
43
|
83
|
5
|
5
|
14
|
12
|
35
|
52
|
69
|
130
|
101
|
46
|
36
|
63
|
73
|
87
|
110
|
125
|
117
|
115
|
125
|
120
|
|
| Other Current Liabilities |
20
|
35
|
7
|
5
|
14
|
16
|
20
|
21
|
21
|
25
|
14
|
12
|
11
|
7
|
119
|
7
|
14
|
8
|
74
|
58
|
52
|
47
|
53
|
25
|
|
| Total Current Liabilities |
150
|
140
|
124
|
178
|
165
|
160
|
218
|
198
|
226
|
259
|
320
|
410
|
370
|
283
|
351
|
231
|
279
|
281
|
285
|
312
|
280
|
253
|
263
|
243
|
|
| Long-Term Debt |
53
|
47
|
54
|
0
|
38
|
34
|
36
|
30
|
3
|
6
|
10
|
4
|
3
|
2
|
0
|
9
|
25
|
48
|
48
|
32
|
26
|
20
|
20
|
22
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
4
|
4
|
5
|
7
|
7
|
4
|
5
|
8
|
6
|
6
|
2
|
2
|
4
|
3
|
4
|
3
|
3
|
2
|
2
|
1
|
|
| Minority Interest |
0
|
0
|
0
|
5
|
16
|
10
|
25
|
22
|
11
|
9
|
9
|
9
|
0
|
2
|
1
|
0
|
0
|
0
|
2
|
2
|
1
|
1
|
1
|
1
|
|
| Other Liabilities |
2
|
2
|
2
|
12
|
24
|
30
|
36
|
34
|
6
|
7
|
8
|
7
|
9
|
11
|
10
|
12
|
9
|
12
|
13
|
11
|
8
|
8
|
4
|
5
|
|
| Total Liabilities |
205
N/A
|
189
-8%
|
180
-5%
|
197
+10%
|
247
+26%
|
237
-4%
|
320
+35%
|
291
-9%
|
252
-13%
|
285
+13%
|
351
+23%
|
438
+25%
|
391
-11%
|
303
-22%
|
364
+20%
|
254
-30%
|
316
+25%
|
344
+9%
|
353
+2%
|
361
+2%
|
318
-12%
|
284
-11%
|
290
+2%
|
273
-6%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
0
|
0
|
9
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
10
|
|
| Retained Earnings |
78
|
60
|
97
|
103
|
102
|
115
|
124
|
136
|
146
|
175
|
202
|
239
|
241
|
241
|
255
|
183
|
200
|
214
|
185
|
198
|
203
|
193
|
157
|
148
|
|
| Additional Paid In Capital |
0
|
0
|
72
|
117
|
117
|
117
|
117
|
117
|
117
|
117
|
118
|
124
|
124
|
124
|
15
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Equity |
4
|
4
|
4
|
11
|
31
|
22
|
29
|
28
|
3
|
6
|
6
|
3
|
6
|
5
|
2
|
3
|
6
|
6
|
9
|
7
|
12
|
12
|
11
|
0
|
|
| Total Equity |
74
N/A
|
56
-25%
|
174
+213%
|
219
+26%
|
199
-9%
|
220
+11%
|
222
+1%
|
234
+6%
|
277
+18%
|
308
+11%
|
336
+9%
|
376
+12%
|
380
+1%
|
381
+0%
|
278
-27%
|
190
-32%
|
204
+7%
|
219
+7%
|
186
-15%
|
201
+8%
|
201
0%
|
191
-5%
|
156
-18%
|
159
+2%
|
|
| Total Liabilities & Equity |
279
N/A
|
245
-12%
|
354
+45%
|
415
+17%
|
446
+7%
|
457
+3%
|
542
+19%
|
525
-3%
|
528
+1%
|
593
+12%
|
687
+16%
|
814
+18%
|
771
-5%
|
684
-11%
|
642
-6%
|
444
-31%
|
520
+17%
|
563
+8%
|
539
-4%
|
562
+4%
|
519
-8%
|
475
-8%
|
446
-6%
|
431
-3%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
675
|
675
|
902
|
993
|
993
|
993
|
993
|
993
|
993
|
993
|
1 000
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
1 034
|
|